Le Lézard
Classified in: Health, Covid-19 virus
Subject: POL

ACEP Rebuts President Trump's False Statements about Overcounting COVID-19 Deaths


WASHINGTON, Oct. 25, 2020 /PRNewswire/ -- In response to President Trump's baseless claims about physicians miscounting deaths due to COVID-19, the American College of Emergency Physicians (ACEP) released the following statement:

"On behalf of the nation's emergency physicians, ACEP is appalled by President Trump's reckless and false assertions that physicians are overcounting deaths related to COVID-19. Emergency physicians and other health care workers have risked their lives day in and day out for almost a year battling the greatest public health crisis in a generation?all while watching countless patients die alone, going to work without sufficient protection equipment, and struggling with crushing anxiety about getting sick or spreading the virus to their loved ones.  

To imply that emergency physicians would inflate the number of deaths from this pandemic to gain financially is offensive, especially as many are actually under unprecedented financial strain as they continue to bear the brunt of COVID-19. These baseless claims not only do a disservice to our health care heroes but promulgate the dangerous wave of misinformation which continues to hinder our nation's efforts to get the pandemic under control and allow our nation to return to normalcy."

The American College of Emergency Physicians (ACEP) is the national medical society representing emergency medicine. Through continuing education, research, public education, and advocacy, ACEP advances emergency care on behalf of its 40,000 emergency physician members, and the more than 150 million Americans they treat on an annual basis. For more information, visit www.acep.org and www.emergencyphysicians.org.

 

 

SOURCE American College of Emergency Physicians (ACEP)


These press releases may also interest you

at 09:00
? R&D activities focused on advancing the development of innovative delivery systems and yeast beta glucan as a potential inhalable therapeutic for COVID-19 ? ? Q3 2020 sales of $3,476,000 compared to $2,908,000 for Q3 2019, representing a 20%...

at 09:00
The "2020 United States Home Gym Equipment Market" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis of the United States Home Gym Equipment Market which includes market sizing, market share by competitor, drivers,...

at 09:00
Ziegler, a specialty investment bank, is pleased to announce its role in advising CareFirst BlueCross BlueShield (CareFirst) in the acquisition of University of Maryland Health Partners (UMHP) and University of Maryland Health Advantage (UMHA) from...

at 08:36
Suraksha Naturals has been tapping into a burgeoning aspect of the supplemental health industry with their natural sprayable supplements that are made utilizing Ayurvedic herbs. Suraksha Natural's goal with their Keto-Veyda product line has been to...

at 08:30
The "Global Neurorehabilitation Device Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The publisher, in its research report, estimates the global neurorehabilitation device market to proliferate with a CAGR of 14.52%...

at 08:05
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces the filing of a registration statement on Form F-4 (the...



News published on 25 october 2020 at 12:41 and distributed by: